27,324,727 Common Stock of Tenaya Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 26-JAN-2022. These Common Stock will be under lockup for 181 days starting from 29-JUL-2021 to 26-JAN-2022.

Details:
The directors and officers, and substantially all securityholders have agreed that, without the prior written consent of Morgan Stanley & Co. LLC, Cowen and Company, LLC and Piper Sandler & Co. on behalf of the underwriters, will not, and will not publicly disclose an intention to, during the period from the date of this prospectus continuing through the date 180 days after the date of this prospectus (the Restricted Period): offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend or otherwise transfer or dispose of, directly or indirectly, any shares of common stock or any securities convertible into or exercisable or exchangeable for shares of common stock.